Form D — OrbiMed Private Investments X, LP
0002087033-26-000001 · filed Apr 30, 2026
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Total offering
- $1,750,000,000
- Total sold
- $1,669,183,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OrbiMed Private Investments X, LP
- CIK
- 2087033
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 601 LEXINGTON AVENUE
NEW YORK, NY 10022 - Phone
- 212-739-6400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A OrbiMed Capital GP X, LP · Executive OfficerNew York, NY Find on LinkedIn ↗
-
N/A OrbiMed Capital GP X LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
N/A OrbiMed Advisors LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Mona Ashiya · Executive OfficerNew York, NY Find on LinkedIn ↗
-
David P. Bonita · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Sven H. Borho · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Carl L. Gordon · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Geoffrey C. Hsu · Executive OfficerNew York, NY Find on LinkedIn ↗
-
W. Carter Neild · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Matthew S. Rizzo · Executive OfficerNew York, NY Find on LinkedIn ↗
-
C. Scotland Stevens · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Peter A. Thompson · Executive OfficerNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗